Industry Overview - On August 18, the medical device industry experienced a rise of 1.45% with a net outflow of main funds amounting to 820 million yuan [1] - A total of 76 constituent stocks increased in value, while 21 stocks saw a decline [1] Fund Flow Analysis - The stocks with the highest net outflow of main funds included Weigao Blood Products (18.8683 million yuan), Shengxiang Biology (16.752 million yuan), New Industry (16.470 million yuan), Dongfulong (15.4047 million yuan), and Weisi Medical (15.0001 million yuan) [1] Stock Performance - Notable stock performances included: - Furuide (60.19 yuan) with a rise of 0.01% and a net inflow of 146 million yuan, accounting for 11.88% of the main fund [1] - Lepu Medical (18.49 yuan) increased by 7.5% with a net inflow of 121 million yuan, representing 7.97% of the main fund [1] - United Imaging (129.66 yuan) saw a 1.33% increase with a net inflow of 87.19 million yuan, making up 8.77% of the main fund [1] - Sanxin Medical (11.11 yuan) rose by 0.89% with a net inflow of 44.13 million yuan, which is 8.05% of the main fund [1] - Sainuo Medical (41.48 yuan) surged by 19.99% with a net inflow of 36.44 million yuan, accounting for 1.44% of the main fund [1] - Huatai Medical (287.92 yuan) decreased by 3.19% with a net outflow of 32.11 million yuan, representing 6.49% of the main fund [1] - Sanofi Biological (21.02 yuan) increased by 0.82% with a net inflow of 30.33 million yuan, making up 9.88% of the main fund [1] - Mindray Medical (236.65 yuan) saw a slight increase of 0.62% with a net inflow of 875.74 thousand yuan, accounting for 1.49% of the main fund [1] - Aide Biological (24.22 yuan) increased by 1.32% with a net inflow of 239.15 thousand yuan, representing 6.53% of the main fund [1] - Mingde Biological (20.98 yuan) rose by 1.01% with a net inflow of 1717.08 thousand yuan, which is 14.09% of the main fund [1]
医疗器械行业18日主力净流出8.21亿元，威高血净、圣湘生物居前